HEDIS Measure: Colorectal Cancer Screening

  • May 7, 2020

    According to the American Cancer Society, colorectal cancer is the third most common cancer diagnosed in the United States. Talk to your patients about the importance of early detection and the types of tests available, including those that are non-invasive.

    FIT (fecal immunochemical test) kits can be sent to patients’ homes so that they can complete screening at home at a time when current social distancing guidance makes getting a screening colonoscopy difficult.

    There are many screenings available for patients to choose from and it’s important for providers to document the type of screening performed or any exclusions in the patient’s medical record. Exclusions for this measure have changed to include advanced illness and frailty of the patient.

    View the Colorectal Cancer Screening tip sheet to learn more about the measure, information to include in a patient’s record, and CPT codes that should be included in claims and tips for talking with patients.

    For more information and/or questions, email ProviderClinicalConsulting@premera.com.

    HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

  •    Email this article